Contrasting SeaStar Medical (ICU) & The Competition

SeaStar Medical (NASDAQ:ICU) is one of 231 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare SeaStar Medical to related companies based on the strength of its valuation, institutional ownership, earnings, profitability, dividends, analyst recommendations and risk.

Insider and Institutional Ownership

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 48.1% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 4.5% of SeaStar Medical shares are held by insiders. Comparatively, 15.2% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares SeaStar Medical and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	N/A	N/A	-741.57%
SeaStar Medical Competitors	-737.51%	-146.94%	-29.30%

Analyst Recommendations

This is a summary of current recommendations for SeaStar Medical and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	0	0	0	0	N/A
SeaStar Medical Competitors	1602	4332	8506	223	2.50

As a group, “Surgical & medical instruments” companies have a potential upside of 25.11%. Given SeaStar Medical’s peers higher probable upside, analysts plainly believe SeaStar Medical has less favorable growth aspects than its peers.

Volatility and Risk

SeaStar Medical has a beta of -0.96, suggesting that its share price is 196% less volatile than the S&P 500. Comparatively, SeaStar Medical’s peers have a beta of 0.61, suggesting that their average share price is 39% less volatile than the S&P 500.

Valuation and Earnings

This table compares SeaStar Medical and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
SeaStar Medical	N/A	-$26.23 million	-0.37
SeaStar Medical Competitors	$1.06 billion	$4.24 million	1.62

SeaStar Medical’s peers have higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

SeaStar Medical peers beat SeaStar Medical on 8 of the 10 factors compared.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.